Viewing Study NCT02593851


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-01-03 @ 4:27 PM
Study NCT ID: NCT02593851
Status: TERMINATED
Last Update Posted: 2019-12-06
First Post: 2015-08-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection
Sponsor: Janssen Sciences Ireland UC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-12-04
Start Date Type: ACTUAL
Primary Completion Date: 2017-03-21
Primary Completion Date Type: ACTUAL
Completion Date: 2017-11-10
Completion Date Type: ACTUAL
First Submit Date: 2015-08-21
First Submit QC Date: None
Study First Post Date: 2015-11-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-12-05
Last Update Post Date: 2019-12-06
Last Update Post Date Type: ACTUAL